Jefferies ’ global head of its private capital group Matthew Wesley is departing the investment bank to join Moelis & Co. Wesley is set to take over as head of private funds advisory at Moelis, six sources familiar with the matter told Secondaries Investor. The Financial Times first published the news.

Shares of Jefferies Financial Group fell in their first trading session since the investment bank reported fourth-quarter earnings that missed analyst expectations. The stock was down 12%, to $70.45, in recent trading Friday. Shares have gained more than 78% in the last 52 weeks.

We recently published a list of 10 Companies Mirror Wall Street Downturn. In this article, we are going to take a look at where Jefferies Financial Group Inc. (NYSE:JEF) stands against other companies mirroring Wall Street downturn.

Mondelez International (NASDAQ:MDLZ – Get Free Report) was downgraded by stock analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a note issued to investors on Tuesday, MarketBeat reports.

Pactiv Evergreen Inc (PTVE) stock saw a modest uptick, ending the day at $17.77 which represents a slight increase of $0.21 or 1.20% from the prior close of $17.56. The stock opened at $17.75 and touched a low of $17.

In a report released today, Zuzanna Pusz from UBS maintained a Buy rating on adidas AG (0OLD – Research Report), with a price target of

In a report released today, Patrick Rafaisz from UBS maintained a Buy rating on Sika AG (SIKA – Research Report), with a price target of

UBS Group upgraded shares of Commercial Metals (NYSE:CMC – Free Report) from a sell rating to a neutral rating in a report released on Friday, Marketbeat reports. UBS Group currently has $54.00 price target on the basic materials company’s stock,

Read about Match Group, Tele2, Deutsche Telekom ... Try GCash, a Philippine fintech firm, has hired banks, including Citi, Jefferies and UBS, to work on an up to $1.5 billion domestic initial ...

Edison International (NYSE:EIX – Get Free Report) had its target price cut by equities research analysts at UBS Group from $87.00 to $69.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the utilities provider’s stock.

Pediatrix Medical Group (NYSE:MD – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a report issued on Wednesday. Other analysts have also recently issued reports about the stock.

Celsius (NASDAQ:CELH – Get Free Report) had its target price reduced by research analysts at UBS Group from $45.00 to $39.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock.